
Paul A. Offit
University of Pennsylvania · Rehabilitation Medicine
Active 1981–2025
About
Paul A. Offit is the Maurice R. Hilleman Chair of Vaccinology and serves as the Chairman of the Therapeutic Standards Committee at The Children’s Hospital of Philadelphia. He is a faculty member in the Department of Pediatrics at the University of Pennsylvania's Perelman School of Medicine, where he is involved in research and education related to vaccines and immunology. His research interests include rotavirus, rotavirus vaccine, intestinal immunity, and vaccine safety. Offit's work has included studying the genetics of rotavirus virulence, the neutralization phenotype of rotavirus, and the protein-specificities of rotavirus-specific cytotoxic T lymphocytes, which contributed to the development of the bovine-human reassortant rotavirus vaccine, RotaTeq, licensed by the FDA in 2006. He devotes his professional time to running the Vaccine Education Center at the Children’s Hospital of Philadelphia, an international center that creates educational materials for parents and healthcare professionals and operates on an endowment. His publications include research on vaccine safety, communication about vaccines, and the development of rotavirus vaccines.
Research topics
- Medicine
- Virology
Selected publications
Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women
JAMA · 2025-06-13 · 7 citations
articleSenior authorThis Viewpoint discusses recent actions by Secretary of Health and Human Services Robert F. Kennedy Jr to rescind the recommendation for COVID-19 vaccines for healthy children and pregnant women, which goes against years of established processes for how vaccines are managed.
Columbia University Press eBooks · 2024-10-09
book1st authorCorrespondingEfficacy of Rotavirus Vaccines
The Pediatric Infectious Disease Journal · 2024-03-20 · 1 citations
articleSenior author*From the University of Pennsylvania, Doylestown, Pennsylvania †Children's Hospital of Philadelphia, Philadelphia, Pennsylvania ‡Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Accepted for publication February 26, 2024 The authors have no funding or conflicts of interest to disclose. Address for correspondence: Stanley A. Plotkin, MD, 4650 Wismer Rd., Doylestown, PA 18902. E-mail: [email protected].
Bivalent Covid-19 Vaccines — A Cautionary Tale
New England Journal of Medicine · 2023-01-11 · 111 citations
articleOpen access1st authorCorrespondingElsevier eBooks · 2023-01-01
book-chapterElsevier eBooks · 2023-01-01
book-chapterSenior authorCOVID-19 Vaccines in Young Children—Reassuring Evidence for Parents
JAMA Pediatrics · 2023-01-23 · 7 citations
letterOpen access1st authorCorrespondingAtsuyuki Watanabe, MD; Ryoma Kani; Masao Iwagami, MD, PhD; Hisato Takagi, MD, PhD; Jun Yasuhara, MD; Toshiki Kuno, MD, PhD
2021-01-01
book-chapter1st authorCorrespondingThe development of COVID-19 vaccines in the United States: Why and how so fast?
Vaccine · 2021-03-26 · 70 citations
articleOpen accessOn the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines
New England Journal of Medicine · 2021-03-20 · 27 citations
articleOpen accessSenior authorOn the Shoulders of Giants The FDA recently authorized two mRNA vaccines for the prevention of Covid-19. Clearance of this hurdle represents the most recent in a series of advances in the realm of ...
Recent grants
NIH · $4.0M · 2005
NIH · $364k · 2001
NIH · $295k · 1993
Frequent coauthors
- 1584 shared
Lawrence David Scahill
- 1420 shared
Alexander Westphal
Yale University
- 1135 shared
Corey Ray-Subramanian
University of Wisconsin–Madison
- 932 shared
Fred R. Volkmar
Yale University
- 852 shared
Jessica L. Roesser
University of Rochester
- 846 shared
Kelly Macy
University of Vermont
- 716 shared
Cheryl Smith Gabig
Lehman College
- 711 shared
Giacomo Vivanti
Drexel University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Paul A. Offit
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup